购物车
- 全部删除
- 您的购物车当前为空
Lintuzumab (HuM-195) 是一种针对细胞表面骨髓单核细胞分化抗原 CD33 的非偶联人源化小鼠单克隆抗体,具有抗白血病活性,可减少 AML 细胞产生 TNFα 诱导的促炎细胞因子和趋化因子。Lintuzumab 具有抗肿瘤活性,通过 CDC 或者 ADCC 直接诱导细胞死亡。
为众多的药物研发团队赋能,
让新药发现更简单!
Lintuzumab (HuM-195) 是一种针对细胞表面骨髓单核细胞分化抗原 CD33 的非偶联人源化小鼠单克隆抗体,具有抗白血病活性,可减少 AML 细胞产生 TNFα 诱导的促炎细胞因子和趋化因子。Lintuzumab 具有抗肿瘤活性,通过 CDC 或者 ADCC 直接诱导细胞死亡。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,360 | 现货 | |
5 mg | ¥ 3,380 | 现货 | |
10 mg | ¥ 4,930 | 现货 | |
25 mg | ¥ 7,760 | 现货 | |
50 mg | ¥ 9,870 | 现货 | |
100 mg | ¥ 13,300 | 现货 |
产品描述 | Lintuzumab (HuM-195) is a non-coupled humanized mouse monoclonal antibody directed against the cell-surface myelomonocyte differentiation antigen, CD33, with anti-leukemic activity that reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells.Lintuzumab has antitumor activity and induces cell death directly via CDC or ADCC. Lintuzumab has anti-tumor activity and induces cell death directly via CDC or ADCC. |
别名 | 林妥珠单抗, SGN-33, SGN33, HuM-195, HuM195 |
CAS No. | 166089-32-3 |
密度 | no data available |
存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容